Examples of antagonist and agonist immunotherapies. Some drugs are function-blocking antibodies, such as those targeting the PD-1/PD-L1 interaction, and some are activating antibodies, such as those targeting the OX40/OX40L interaction. It depends on the downstream pathway and cellular context. By Nancy R. Gough, Bioserendipity, LLC